COMMUNIQUÉS West-GlobeNewswire

Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib in Relapsed or Refractory FLT3-Positive AML

01/12/2017 - 13:00

DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]

Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market

01/12/2017 - 13:00

NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]

Notice Received Under Section 249D of the Corporations Act

01/12/2017 - 11:00

MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”), advises that on 29 November it received a notice under Section 249D of the Corporations Act [...]

Employee elected board member change in Zealand Pharma

01/12/2017 - 09:20

Company announcement - No. 54/2017 Employee elected board member change in Zealand Pharma Copenhagen, December 1, 2017 - Zealand Pharma A/S ("ZEAL") announces that Rasmus Just, Director of Business Development and [...]

Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology

01/12/2017 - 08:33

Oslo, Norway, December 1, 2017 Photocure ASA (OSE: PHO) announced today that more detailed data from the Phase 3 study data was presented at the prestigious Society of Urologic Oncology, Annual Meeting November 29 - [...]

Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America

01/12/2017 - 08:01

Company announcement, Helsinki, 1 December 2017 at 9 am Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical [...]

Basilea extends existing license agreement with Pfizer for antifungal Cresemba® (isavuconazole) to China and Asia Pacific

01/12/2017 - 07:16

Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales Basilea updates its financial guidance for 2017 - improved result expected Basel, [...]

Cannabis Wheaton Income Corp. Announces Option Grant

01/12/2017 - 06:01

VANCOUVER, British Columbia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") announces that it has granted 6,045,000 options to [...]

Veloxis Increases Share Capital in Connection with Exercise of Warrants

01/12/2017 - 06:00

Company Release no. 24/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 01 December 2017 Veloxis Increases Share Capital in Connection with Exercise of Warrants Veloxis Pharmaceuticals A/S announces that the Company' [...]

CORRECTION -- Skyline Medical Inc. Announces the Completion of Private Placement for Gross Proceeds of $1,300,000

01/12/2017 - 03:54

BOCA RATON, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Please note that this is a headline correction for a release published earlier today for Skyline Medical Inc. The original release follows. Dawson James Securities, [...]

Globus Medical Announces Clinical Results Showing Superiority of its SECURE-C® to ACDF at Seven Years

01/12/2017 - 01:30

AUDUBON, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced the results of its seven-year clinical trial follow-up that demonstrate [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/12/2017 - 00:30

CAMBRIDGE, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

Bellerophon Appoints Ted Wang, Ph.D., of Puissance Capital Management, to its Board of Directors

30/11/2017 - 23:46

WARREN, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today announced the appointment of Ted Wang, Ph.D., Chief Investment Officer of [...]

Dawson James Securities Announces the Completion of Private Placement for Skyline Medical Inc. for Gross Proceeds of $1,300,000

30/11/2017 - 23:15

BOCA RATON, Fla., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Dawson James Securities, Inc. in conjunction with Skyline Medical Inc. closed a private placement of a newly created series of preferred stock designated as “Series C [...]

MPX Bioceutical Corporation Announces $25 Million Private Placement of Units

30/11/2017 - 23:07

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF) (the “Company” or “MPX”) announced today that it has entered into an agreement [...]

Retrophin to Present at the BMO 2017 Prescriptions for Success Healthcare Conference

30/11/2017 - 22:30

SAN DIEGO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Stephen Aselage, chief executive officer, will present at the BMO 2017 Prescriptions for Success Healthcare Conference in [...]

CAPS® to Showcase Its Quality Assurance Programs at ASHP

30/11/2017 - 22:15

IRVINE, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS) will showcase its 503B compounded drugs 100 percent release testing quality assurance program at this year’s American [...]

Vilacto Bio, Inc. Issues Statement About Promotional Activity Concerning Its Common Stock

30/11/2017 - 22:06

COPENHAGEN, Denmark, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio, Inc. the “Company” (OTCQB:VIBI), today announced that it has been made aware of certain promotional activity concerning VIBI common stock. On November [...]

Global Blood Therapeutics Announces New Employment Inducement Grants

30/11/2017 - 22:05

SOUTH SAN FRANCISCO, Calif., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that the compensation committee of the Company’s board of directors granted two new [...]